Susanne Ramey
Family · la Porte, TXNPI 1093056210
Payments from drug & device makers
Across 151 payments — averaging $17.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$337
- AbbVie$309
- AstraZeneca$306
- GSK$226
- Novo Nordisk$226
- Nestle Healthcare Nutrition Inc.$222
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,663100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 21 | $337 |
| AbbVie | 19 | $309 |
| AstraZeneca | 17 | $306 |
| GSK | 13 | $226 |
| Novo Nordisk | 13 | $226 |
| Nestle Healthcare Nutrition Inc. | 12 | $222 |
| Boehringer Ingelheim | 7 | $135 |
| Bayer | 6 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $99 |
| Johnson & Johnson | 6 | $95 |
| Lilly USA, LLC | 4 | $76 |
| Avanir Pharmaceuticals, Inc. | 3 | $58 |
| Jazz Pharmaceuticals Inc. | 3 | $56 |
| Heartflow, Inc. | 1 | $48 |
| Esperion Therapeutics, Inc. | 2 | $40 |
| Endo Pharmaceuticals Inc. | 3 | $39 |
| Biohaven Pharmaceuticals, Inc. | 2 | $37 |
| Vivus LLC | 2 | $33 |
| Amgen | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $25 |
| Boston Scientific | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Pfizer | 1 | $21 |
| Merck | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Novartis | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$2,663 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olmesartan Medoxomil | 16 | $1,711 |
| Atorvastatin Calcium | 57 | $1,554 |
| Losartan Potassium | 21 | $474 |
| Pravastatin Sodium | 13 | $457 |
| Omeprazole | 14 | $405 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $328 |
| Lisinopril | 22 | $225 |
| Pantoprazole Sodium | 11 | $202 |
| Amlodipine Besylate | 29 | $190 |
| Metformin Hcl | 20 | $173 |
| Alendronate Sodium | 11 | $147 |
| Methylprednisolone | 12 | $64 |
| Levothyroxine Sodium | 14 | $58 |
Paid to pharmacies, not to this prescriber.
Other family in la Porte
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.